Rchr
J-GLOBAL ID:201801000954437386   Update date: Sep. 06, 2024

Toshimitsu Yamaoka

ヤマオカ トシミツ | Toshimitsu Yamaoka
Affiliation and department:
Research keywords  (3): 薬剤耐性 ,  チロシンキナーゼ阻害剤 ,  EGFR
Research theme for competitive and other funds  (6):
  • 2016 - 2019 Investigate the role of TNF and EGFR in the onset and progression of lung cancer complicated with COPD
  • 2013 - 2016 The potential mechanisms of EGFR-TKI induced lung injury in mice model
  • 2010 - 2014 The role of ADAM17 in squamous cell lung cancer
  • 2011 - 2013 Elucidation of trans-activation mechanism from TRAIL receptor to EGFR
  • 2011 - 2013 Association of pharmacokinetics or pharmacogenomics with toxicity of erlotinib in patients with advanced non-small cell lung cancer
Show all
Papers (70):
  • Koichi Ando, Ryo Manabe, Yasunari Kishino, Sojiro Kusumoto, Toshimitsu Yamaoka, Akihiko Tanaka, Tohru Ohmori, Hironori Sagara. Comparative Efficacy of ALK Inhibitors for Treatment-Naïve ALK-Positive Advanced Non-Small Cell Lung Cancer with Central Nervous System Metastasis: A Network Meta-Analysis. International journal of molecular sciences. 2023. 24. 3
  • Shigetoshi Nishihara, Toshimitsu Yamaoka, Fumihiro Ishikawa, Kensuke Higuchi, Yuki Hasebe, Ryo Manabe, Yasunari Kishino, Sojiro Kusumoto, Koichi Ando, Yusuke Kuroda, et al. Mechanisms of EGFR-TKI-Induced Apoptosis and Strategies Targeting Apoptosis in EGFR-Mutated Non-Small Cell Lung Cancer. Genes. 2022. 13. 12
  • 山岡 利光, 長谷部 友紀, 眞鍋 亮, 岸野 康成, 楠本 壮二郎, 安藤 浩一, 大森 亨, 相良 博典, 鶴谷 純司. 肺腺癌細胞PC-9におけるオシメルチニブの獲得耐性機序の検討. 肺癌. 2022. 62. 6. 753-753
  • 山岡 利光, 長谷部 友紀, 眞鍋 亮, 岸野 康成, 楠本 壮二郎, 安藤 浩一, 大森 亨, 相良 博典, 鶴谷 純司. 肺腺癌細胞PC-9におけるオシメルチニブの獲得耐性機序の検討. 肺癌. 2022. 62. 6. 753-753
  • 西原 成俊, 山岡 利光, 長谷部 友紀, 石川 文博, 楠本 壮二郎, 大森 亨, 相良 博典, 吉田 仁, 鶴谷 純司. 肺腺癌細胞における第3世代EGFR-TKIオシメルチニブの獲得耐性機序の検討(Resistance mechanisms against osimertinib in lung adenocarcinoma cells with EGFR-activating mutation). 日本癌学会総会記事. 2022. 81回. P-2365
more...
MISC (183):
more...
Education (2):
  • 1998 - 2002 Showa University Guraduate School of Medical Sciences
  • 1992 - 1998 Showa University School of Medicine
Professional career (1):
  • Ph.D (Showa University)
Work history (8):
  • 2018/08 - 現在 Showa University Advanced Cancer Translational Institute Associate Professor
  • 2017/12 - 2018/08 Showa University Institute of Molecular Oncology,Showa University
  • 2011/10 - 2017/12 Showa University Institute of Molecular Oncology,Showa University
  • 2011/09 - 2011/10 Showa University
  • 2008/04 - 2011/08 昭和大学 呼吸器・アレルギー内科 助教
Show all
Awards (2):
  • 2017/06 - 昭和大学医学部同窓会 平成29年度昭和大学医学部同窓会学術研究助成
  • 2009/11 - 東京呼吸病態研究会 第13回東京呼吸病態研究会 優秀発表賞
Association Membership(s) (10):
American Society of Clinical Oncology ,  American Association for Cancer Research ,  JAPANESE SOCIETY OF ALLERGOLOGY ,  日本臨床腫瘍学会 ,  THE JAPAN LUNG CANCER SOCIETY ,  THE JAPANESE CANCER ASSOCIATION ,  THE JAPANESE ASSOCIATION FOR MOLECULAR TARGET THERAPY OF CANCER ,  THE JAPAN SOCIETY FOR RESPIRATORY ENDOSCOPY ,  THE JAPANESE RESPIRATORY SOCIETY ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page